How Stemlike Are Sphere Cultures From Long-term Cancer Cell Lines? Lessons From Mouse Glioma Models

Abstract Cancer stem cells may mediate therapy resistance and recurrence in various types of cancer, including glioblastoma. Cancer stemlike cells can be isolated from long-term cancer cell lines, including glioma lines. Using sphere formation as a model for cancer cell stemness in vitro, we derived sphere cultures from SMA-497, SMA-540, SMA-560, and GL-261 glioma cells. Gene expression and proteomics profiling demonstrated that sphere cultures uniformly showed an elevated expression of stemness-associated genes, notably including CD44. Differences in neural lineage marker expression between nonsphere and sphere cultures were heterogeneous except for a uniform reduction of &bgr;-III-tubulin in sphere cultures. All sphere cultures showed slower growth. Self-renewal capacity was influenced by medium conditions but not nonsphere versus sphere culture phenotype. Sphere cultures were more resistant to irradiation, whereas both nonsphere and sphere cultures were highly resistant to temozolomide. Nonsphere cells formed more aggressive tumors in syngeneic mice than sphere cells in all models except SMA-560. There were no major differences in vascularization or infiltration by T cells or microglia/macrophages between nonsphere and sphere cell–derived tumors implanted in syngeneic hosts. Together, these data indicate that mouse glioma cell lines may be induced in vitro to form spheres that acquire features of stemness, but they do not exhibit a uniform biologic phenotype, thereby challenging the view that they represent a superior model system.

[1]  G. Reifenberger,et al.  EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma. , 2014, The Lancet. Oncology.

[2]  Mario Fasold,et al.  Portraying the expression landscapes of cancer subtypes , 2013 .

[3]  E. Helseth,et al.  A population-based study on the effect of temozolomide in the treatment of glioblastoma multiforme. , 2012, Neuro-oncology.

[4]  Z. Naito,et al.  CD44 in human glioma correlates with histopathological grade and cell migration , 2012, Pathology international.

[5]  Rolf Bjerkvig,et al.  In vivo models of primary brain tumors: pitfalls and perspectives , 2012, Neuro-oncology.

[6]  Leandro Martínez,et al.  Medium Chain Fatty Acids Are Selective Peroxisome Proliferator Activated Receptor (PPAR) γ Activators and Pan-PPAR Partial Agonists , 2012, PloS one.

[7]  Hideyuki Okano,et al.  RNA-Binding Protein Musashi1 Modulates Glioma Cell Growth through the Post-Transcriptional Regulation of Notch and PI3 Kinase/Akt Signaling Pathways , 2012, PloS one.

[8]  Lindy E. Barrett,et al.  Self-renewal does not predict tumor growth potential in mouse models of high-grade glioma. , 2012, Cancer cell.

[9]  Tomasz Stokowy,et al.  MALDI-typing of infectious algae of the genus Prototheca using SOM portraits. , 2012, Journal of microbiological methods.

[10]  Martin von Bergen,et al.  Mining SOM expression portraits: feature selection and integrating concepts of molecular function , 2011, BioData Mining.

[11]  Xiaosheng Wang.  Computational analysis of expression of human embryonic stem cell-associated signatures in tumors , 2011, BMC Research Notes.

[12]  Martin von Bergen,et al.  Expression cartography of human tissues using self organizing maps , 2011, BMC Bioinformatics.

[13]  Erika Pastrana,et al.  Eyes wide open: a critical review of sphere-formation as an assay for stem cells. , 2011, Cell stem cell.

[14]  M. Westphal,et al.  A distinct subset of glioma cell lines with stem cell‐like properties reflects the transcriptional phenotype of glioblastomas and overexpresses CXCR4 as therapeutic target , 2011, Glia.

[15]  J. Baselga,et al.  TGF-β Receptor Inhibitors Target the CD44(high)/Id1(high) Glioma-Initiating Cell Population in Human Glioblastoma. , 2010, Cancer cell.

[16]  C. Tseng,et al.  Evaluation of the prognostic value of CD44 in glioblastoma multiforme. , 2010, Anticancer research.

[17]  Michael Sabel,et al.  Genomic and Expression Profiling of Glioblastoma Stem Cell–Like Spheroid Cultures Identifies Novel Tumor-Relevant Genes Associated with Survival , 2009, Clinical Cancer Research.

[18]  Yong Yang,et al.  Isolation and characterization of cancer stem like cells in human glioblastoma cell lines. , 2009, Cancer letters.

[19]  Mark Bernstein,et al.  Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens. , 2009, Cell stem cell.

[20]  Austin G Smith,et al.  CD133 (Prominin) Negative Human Neural Stem Cells Are Clonogenic and Tripotent , 2009, PloS one.

[21]  Xinyu Wang,et al.  Detection of Cancer Stem Cells from the C6 Glioma Cell Line , 2009, The Journal of international medical research.

[22]  Stephan Preibisch,et al.  "Hook"-calibration of GeneChip-microarrays: Chip characteristics and expression measures , 2008, Algorithms for Molecular Biology.

[23]  Dong-Sup Lee,et al.  Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas , 2008, Laboratory Investigation.

[24]  G. Reifenberger,et al.  Temozolomide preferentially depletes cancer stem cells in glioblastoma. , 2008, Cancer research.

[25]  Xiaofeng Yang,et al.  Identification of cancer stem-like cells in the C6 glioma cell line and the limitation of current identification methods , 2008, In Vitro Cellular & Developmental Biology - Animal.

[26]  W. Hall,et al.  Persistence of CD133+ cells in human and mouse glioma cell lines: detailed characterization of GL261 glioma cells with cancer stem cell-like properties. , 2008, Stem cells and development.

[27]  Yuri Kotliarov,et al.  Genomic Changes and Gene Expression Profiles Reveal That Established Glioma Cell Lines Are Poorly Representative of Primary Human Gliomas , 2008, Molecular Cancer Research.

[28]  Mark W. Dewhirst,et al.  Glioma stem cells promote radioresistance by preferential activation of the DNA damage response , 2006, Nature.

[29]  K. Black,et al.  Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma , 2006, Molecular Cancer.

[30]  F. Menghi,et al.  Neurospheres enriched in cancer stem-like cells are highly effective in eliciting a dendritic cell-mediated immune response against malignant gliomas. , 2006, Cancer research.

[31]  L. Ricci-Vitiani,et al.  Chemotherapy resistance of glioblastoma stem cells , 2006, Cell Death and Differentiation.

[32]  R. Henkelman,et al.  Identification of human brain tumour initiating cells , 2004, Nature.

[33]  Ugo Orfanelli,et al.  Isolation and Characterization of Tumorigenic, Stem-like Neural Precursors from Human Glioblastoma , 2004, Cancer Research.

[34]  D. Bigner,et al.  Tumorigenic cell culture lines from a spontaneous VM/Dk murine astrocytoma (SMA) , 2004, Acta Neuropathologica.

[35]  Rafael A Irizarry,et al.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.

[36]  D. Steindler,et al.  Human cortical glial tumors contain neural stem‐like cells expressing astroglial and neuronal markers in vitro , 2002, Glia.

[37]  P. Braun,et al.  Transcriptional Regulation of 2′,3′‐Cyclic Nucleotide 3′‐Phosphodiesterase Gene Expression by Cyclic AMP in C6 Cells , 2000, Journal of neurochemistry.

[38]  Daniel A. Lim,et al.  Subventricular Zone Astrocytes Are Neural Stem Cells in the Adult Mammalian Brain , 1999, Cell.

[39]  S. Scherer,et al.  Differential regulation of the 2′,3′-cyclic nucleotide 3′-phosphodiesterase gene during oligodendrocyte development , 1994, Neuron.

[40]  V. Neuhoff,et al.  Improved staining of proteins in polyacrylamide gels including isoelectric focusing gels with clear background at nanogram sensitivity using Coomassie Brilliant Blue G‐250 and R‐250 , 1988, Electrophoresis.

[41]  H. Fraser.  Astrocytomas in an inbred mouse strain , 1971, The Journal of pathology.

[42]  D. Rall,et al.  Studies on the chemotherapy of experimental brain tumors: development of an experimental model. , 1970, Cancer research.

[43]  H. M. Zimmerman,et al.  Experimental Brain Tumors: II. Tumors Produced with Benzpyrene. , 1943, The American journal of pathology.